Free Trial

MyHealthChecked (MHC) Competitors

MyHealthChecked logo
GBX 13.20 -0.80 (-5.71%)
As of 04/17/2025 03:33 AM Eastern

MHC vs. IHC, POLX, AVO, RUA, SUN, BELL, DEMG, NIOX, SN, and MXCT

Should you be buying MyHealthChecked stock or one of its competitors? The main competitors of MyHealthChecked include Inspiration Healthcare Group (IHC), Polarean Imaging (POLX), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Belluscura (BELL), Deltex Medical Group (DEMG), NIOX Group (NIOX), Smith & Nephew (SN), and MaxCyte (MXCT). These companies are all part of the "medical devices" industry.

MyHealthChecked vs.

MyHealthChecked (LON:MHC) and Inspiration Healthcare Group (LON:IHC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment, community ranking and analyst recommendations.

In the previous week, MyHealthChecked's average media sentiment score of 0.00 equaled Inspiration Healthcare Group'saverage media sentiment score.

Company Overall Sentiment
MyHealthChecked Neutral
Inspiration Healthcare Group Neutral

MyHealthChecked has a net margin of -11.06% compared to Inspiration Healthcare Group's net margin of -28.46%. MyHealthChecked's return on equity of -12.80% beat Inspiration Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
MyHealthChecked-11.06% -12.80% -8.18%
Inspiration Healthcare Group -28.46%-34.30%-3.47%

3.1% of MyHealthChecked shares are held by institutional investors. Comparatively, 46.1% of Inspiration Healthcare Group shares are held by institutional investors. 53.6% of MyHealthChecked shares are held by company insiders. Comparatively, 31.8% of Inspiration Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

MyHealthChecked has higher earnings, but lower revenue than Inspiration Healthcare Group. MyHealthChecked is trading at a lower price-to-earnings ratio than Inspiration Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MyHealthChecked£9.43M0.73-£1.04M-£2.00-6.58
Inspiration Healthcare Group£42.87M0.34-£12.20M-£14.58-1.14

Inspiration Healthcare Group received 103 more outperform votes than MyHealthChecked when rated by MarketBeat users.

CompanyUnderperformOutperform
MyHealthCheckedN/AN/A
Inspiration Healthcare GroupOutperform Votes
103
68.21%
Underperform Votes
48
31.79%

MyHealthChecked has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Comparatively, Inspiration Healthcare Group has a beta of 0.09, suggesting that its stock price is 91% less volatile than the S&P 500.

Summary

MyHealthChecked beats Inspiration Healthcare Group on 7 of the 12 factors compared between the two stocks.

Get MyHealthChecked News Delivered to You Automatically

Sign up to receive the latest news and ratings for MHC and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MHC vs. The Competition

MetricMyHealthCheckedMedical Devices IndustryMedical SectorLON Exchange
Market Cap£6.87M£3.03B£5.31B£2.51B
Dividend YieldN/A2.45%5.45%4.79%
P/E Ratio-6.5863.5921.94130.39
Price / Sales0.73113.75380.95234,570.21
Price / Cash1.7815.9938.2628.26
Price / Book0.913.646.454.42
Net Income-£1.04M£126.02M£3.22B£5.88B
1 Month Performance-12.00%-7.13%-9.76%-1.35%
1 Year Performance18.97%-13.44%11.49%41.32%

MyHealthChecked Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MHC
MyHealthChecked
N/AGBX 13.20
-5.7%
N/A+27.2%£6.87M£9.43M-6.5816Gap Down
IHC
Inspiration Healthcare Group
N/AGBX 16.50
-1.5%
N/A-43.2%£14.29M£42.87M-1.13224
POLX
Polarean Imaging
N/AGBX 0.93
-4.5%
N/A-73.3%£13.66M£5.21M-0.2428
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
RUA
RUA Life Sciences
N/AGBX 11.27
+2.5%
N/A+1.6%£6.99M£4.05M-2.6348Gap Up
SUN
Surgical Innovations Group
N/AGBX 0.55
+9.6%
N/A-9.1%£5.11M£12.54M-21.1180Gap Up
BELL
Belluscura
N/AGBX 0.75
-9.1%
N/A-92.3%£1.89M£2.87M-0.0824Gap Down
High Trading Volume
DEMG
Deltex Medical Group
N/AN/AN/AN/A£187,000.00£1.76M-0.1537Gap Up
High Trading Volume
NIOX
NIOX Group
2.4689 of 5 stars
GBX 66.20
-3.8%
N/A-9.0%£27.19B£3.53B2,731.9692Analyst Forecast
SN
Smith & Nephew
3.2955 of 5 stars
GBX 991.60
+1.2%
GBX 4,607.50
+364.7%
+2.4%£10.87B£7.08B35.7018,452Gap Up
High Trading Volume
MXCT
MaxCyte
N/AGBX 183
-7.1%
N/A-37.7%£241.57M£57.52M-6.7180News Coverage
Gap Down

Related Companies and Tools


This page (LON:MHC) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners